167 related articles for article (PubMed ID: 32702646)
1. Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Wang W; Liu H; Guo W; Li P; Deng M
Transl Oncol; 2020 Nov; 13(11):100835. PubMed ID: 32702646
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis.
Qiao W; Jia Z; Guo W; Liu Q; Guo X; Deng M
Mol Diagn Ther; 2023 Sep; 27(5):573-582. PubMed ID: 37464212
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis.
Liu B; Peng Q; Wang YW; Qiu J; Zhu J; Ma R
Front Oncol; 2023; 13():1153076. PubMed ID: 37124526
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis.
Zeng XQ; Li N; Ma LL; Tseng YJ; Zhao NQ; Chen SY
PLoS One; 2016; 11(9):e0162666. PubMed ID: 27637100
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis.
Qiao W; Liu H; Liu R; Liu Q; Zhang T; Guo W; Li P; Deng M
Clin Chim Acta; 2018 Aug; 483():209-215. PubMed ID: 29738697
[TBL] [Abstract][Full Text] [Related]
7. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.
Wu Q; Ma G; Deng Y; Luo W; Zhao Y; Li W; Zhou Q
Front Oncol; 2019; 9():1068. PubMed ID: 31681601
[No Abstract] [Full Text] [Related]
9. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.
Li X; Li M; Lian Z; Zhu H; Kong L; Wang P; Yu J
Target Oncol; 2016 Dec; 11(6):753-761. PubMed ID: 27422273
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis.
Liu H; Li Z; Deng M; Liu Q; Zhang T; Guo W; Li P; Qiao W
Clin Chim Acta; 2018 Sep; 484():72-80. PubMed ID: 29800557
[TBL] [Abstract][Full Text] [Related]
12. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
13. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis.
Zhao G; Wang X; Qu L; Zhu Z; Hong J; Hou H; Li Z; Wang J; Lv Z
Breast Care (Basel); 2021 Feb; 16(1):16-26. PubMed ID: 33716628
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
15. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Focal Adhesion Kinase in Node-Negative Breast Cancer.
Almstedt K; Sicking I; Battista MJ; Huangfu S; Heimes AS; Weyer-Elberich V; Hasenburg A; Schmidt M
Breast Care (Basel); 2017 Oct; 12(5):329-333. PubMed ID: 29234254
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling.
Vishnubalaji R; Shaath H; Elkord E; Alajez NM
Cell Death Discov; 2019; 5():109. PubMed ID: 31263577
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
19. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
Yan S; Jiao X; Li K; Li W; Zou H
Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
[TBL] [Abstract][Full Text] [Related]
20. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.
Schmitz KJ; Grabellus F; Callies R; Otterbach F; Wohlschlaeger J; Levkau B; Kimmig R; Schmid KW; Baba HA
Breast Cancer Res; 2005; 7(2):R194-203. PubMed ID: 15743500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
